Acetylamantadine Excretion by Cancer Patients

UnknownOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Cancer
Interventions
DRUG

Amantadine

Amantadine is a drug that has been on the market for several years and is currently approved for the treatment of Parkinson's disease and for prevention against influenza A infection. Amantadine may be of value in detecting the presence of cancer.

Trial Locations (1)

R2H 2A6

RECRUITING

St. Boniface Hospital, Winnipeg

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioMark Technologies Inc.

INDUSTRY

collaborator

St. Boniface Hospital

OTHER

lead

University of Manitoba

OTHER